ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection
November 26, 2021Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address acute medical conditions and public health threats... -
Taffix® blocks the Delta Variant of SARS-CoV-2 in addition to the Alpha (UK) and Beta (South African) Variant
July 20, 2021Nasus Pharma today announced data from a collaborative in vitro study with the Central Virology Laboratory, Ministry of Health, Public Health Services, Sheba Medical Center, which demonstrated that the gel layer produced by Taffix®
Pharma Sources Insight January 2025
